Texas GOP Senate Candidate Ken Paxton Received $500K+ in Alcohol Donations

Campaign Finance Disclosures Show Pattern of Alcohol Industry Support

Ken Paxton's campaign committees accepted $537,400 from alcohol distributors, brewers, and industry trade groups during his tenure as Texas Attorney General and his current Senate campaign. The money came from entities including the Beer Alliance of Texas ($82,000), Glazer's Distributors ($45,000), and Southern Glazer's Wine & Spirits ($38,500), per Texas Ethics Commission filings reviewed September 24, 2026.

The donor list includes:

• Beer Alliance of Texas: $82,000
• Glazer's Distributors: $45,000
• Southern Glazer's Wine & Spirits: $38,500
• Anheuser-Busch affiliated PACs: $31,200
• Texas Package Stores Association: $28,700

Paxton's office didn't respond to a request for comment by press time.

Paxton Opposed Five Cannabis Reform Bills Since 2021

Paxton issued formal legal opinions opposing HB 1535 (medical cannabis expansion), HB 441 (decriminalization), SB 140 (THC possession penalty reduction), HB 2593 (compassionate use program expansion), and HB 1648 (adult-use legalization framework) between 2021 and 2026. Each opinion cited public-safety concerns and federal Schedule I classification under the Controlled Substances Act.

In a March 2025 opinion on HB 1535, Paxton wrote that expanding medical cannabis access "conflicts with federal law and exposes Texas municipalities to enforcement risk." The bill would've added chronic pain and PTSD to the state's Compassionate Use Program qualifying conditions.

On a strict reading of Texas Health and Safety Code §481.111, Paxton's office argued that any expansion beyond the current low-THC program (≤1% THC by weight) would require federal rescheduling first. That threshold remains the nation's most restrictive.

Alcohol Industry Has Lobbied Against Texas Cannabis Bills

The Beer Alliance of Texas, Texas Package Stores Association, and Wine & Spirits Wholesalers of Texas collectively spent $1.2 million lobbying against cannabis legislation in the 2025 legislative session. Lobby disclosure forms filed with the Texas Ethics Commission show the groups registered opposition to HB 1535, HB 441, and SB 140.

The alcohol lobby's spending against cannabis reform in Texas exceeded the combined budget of all pro-legalization advocacy groups in the state by a factor of three.

Texas NORML reported raising $387,000 for the 2025 session. Texans for Responsible Marijuana Policy raised $112,000. The disparity in lobbying firepower has stalled reform efforts despite polling showing 68% of Texas voters support medical cannabis expansion, per a University of Texas / Texas Tribune poll conducted in June 2026.

Federal Tax Code Creates Incentive Misalignment

Under IRC §280E, cannabis businesses can't deduct ordinary business expenses—a restriction that doesn't apply to alcohol retailers or distributors. The tax treatment creates a structural advantage for alcohol industry competitors opposing state-level cannabis legalization.

A licensed Texas dispensary operating under the Compassionate Use Program pays an effective federal tax rate of 70–85% because it can't deduct rent, payroll, or compliance costs. Alcohol distributors face the standard 21% corporate rate. They deduct all ordinary expenses.

The Beer Alliance of Texas didn't respond to questions about whether its opposition to cannabis reform is informed by competitive market-share concerns.

Texas Compassionate Use Program Remains Nation's Most Restrictive

Texas limits medical cannabis to patients with epilepsy, terminal cancer, autism, or PTSD, with a maximum THC concentration of 1% by weight. Only 15,400 patients are enrolled in the program as of August 2026, according to the Texas Department of Public Safety Compassionate Use Registry.

By comparison:

• Oklahoma (medical program): 381,000 active patient cards, 10% THC limit for flower
• Arkansas (medical program): 92,000 active cards, no THC cap
• Louisiana (medical program): 48,000 active cards, 30% THC limit for flower

Texas physicians can recommend low-THC cannabis but can't prescribe it, a distinction that limits insurance reimbursement pathways and increases patient out-of-pocket costs to $200–$400 per month on average.

What Happens Next in the Texas Senate Race

Paxton faces a competitive GOP primary in March 2027, with two challengers who've signaled openness to medical cannabis expansion. State Senator Angela Paxton (no relation) and former Land Commissioner George P. Bush both declined to take a position on HB 1535 during the 2025 session but have since indicated they'd support adding chronic pain as a qualifying condition.

For full background on this story, see the CannIntel topic hub on Texas cannabis reform. The general election is scheduled for November 2027. Early polling shows Paxton leading the GOP field with 41% support, per a Texas Lyceum poll released September 18, 2026.

The next campaign finance filing deadline is January 15, 2027. We'll be watching whether alcohol industry contributions continue at the same pace and whether Paxton modifies his public stance on cannabis as the primary approaches.